BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12864742)

  • 1. The role of intramuscular lipid in insulin resistance.
    Hegarty BD; Furler SM; Ye J; Cooney GJ; Kraegen EW
    Acta Physiol Scand; 2003 Aug; 178(4):373-83. PubMed ID: 12864742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.
    Kraegen EW; Cooney GJ; Ye J; Thompson AL
    Exp Clin Endocrinol Diabetes; 2001; 109(4):S516-26. PubMed ID: 11453039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle long-chain acyl CoA esters and insulin resistance.
    Cooney GJ; Thompson AL; Furler SM; Ye J; Kraegen EW
    Ann N Y Acad Sci; 2002 Jun; 967():196-207. PubMed ID: 12079848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle insulin resistance: assault by lipids, cytokines and local macrophages.
    Kewalramani G; Bilan PJ; Klip A
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):382-90. PubMed ID: 20495453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat.
    Laybutt DR; Schmitz-Peiffer C; Saha AK; Ruderman NB; Biden TJ; Kraegen EW
    Am J Physiol; 1999 Dec; 277(6):E1070-6. PubMed ID: 10600797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
    Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
    Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.
    Kraegen EW; Cooney GJ; Ye JM; Thompson AL; Furler SM
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S189-201. PubMed ID: 11460570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats.
    Mullen KL; Pritchard J; Ritchie I; Snook LA; Chabowski A; Bonen A; Wright D; Dyck DJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R243-51. PubMed ID: 19073900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.
    Ye JM; Iglesias MA; Watson DG; Ellis B; Wood L; Jensen PB; Sørensen RV; Larsen PJ; Cooney GJ; Wassermann K; Kraegen EW
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E531-40. PubMed ID: 12556350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
    Ye JM; Doyle PJ; Iglesias MA; Watson DG; Cooney GJ; Kraegen EW
    Diabetes; 2001 Feb; 50(2):411-7. PubMed ID: 11272155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin, skeletal muscle lipids, and lipid-induced insulin resistance.
    Dube JJ; Bhatt BA; Dedousis N; Bonen A; O'Doherty RM
    Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R642-50. PubMed ID: 17491114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscular diacylglycerol metabolism and insulin resistance.
    Timmers S; Schrauwen P; de Vogel J
    Physiol Behav; 2008 May; 94(2):242-51. PubMed ID: 18207474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-resistant female rat skeletal muscles display diacylglycerol-mediated protein kinase C activation and inflammation without ceramide accumulation.
    Jani S; Da Eira D; Ceddia RB
    J Physiol; 2023 May; 601(10):1745-1759. PubMed ID: 36905219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.